Loading... Please wait...

Armata Pharmaceuticals, Inc. (ARMP) Ownership

Currency in USD Disclaimer
$2.67 $0.14 (5.53%)
$2.42
$2.67
$1.07
$5.26
  • RECENT QUARTER TOTAL INVESTED

    $5.93 M

      $1.76 M

  • RECENT QUARTER INSTITUTIONAL OWNERSHIP PERCENTAGE

    3.93%

      0.36%

  • TOTAL INVESTED OF LAST QUARTER

    $4.17 M
  • OWNERSHIP PERCENTAGE OF LAST QUARTER

    3.57%
*Showing results of the last quarter update as of 03/31/2024

Armata Pharmaceuticals, Inc. Major Shareholders & Ownership History


Reporting Date Major Shareholder Name Shares Held Market Value Change in Shares Ownership
05/15/2024 BANK OF AMERICA CORP /DE/ 636,638 $2.66 M   0.34% 1.76%
05/10/2024 VANGUARD GROUP INC 159,209 $665,494   9.74% 0.44%
05/15/2024 BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,382 $461,397   0.00% 0.31%
05/14/2024 EDGEWOOD MANAGEMENT LLC 100,000 $418,000   0.00% 0.28%
05/13/2024 GEODE CAPITAL MANAGEMENT, LLC 99,888 $417,648   -1.11% 0.28%
05/07/2024 SUSQUEHANNA INTERNATIONAL GROUP, LLP 87,803 $367,017   100.00% 0.24%
05/13/2024 RENAISSANCE TECHNOLOGIES LLC 51,396 $215,000   -4.10% 0.14%
05/15/2024 STATE STREET CORP 40,300 $168,454   0.00% 0.11%
04/18/2024 SEACREST WEALTH MANAGEMENT, LLC 32,777 $137,008   80.79% 0.09%
05/10/2024 BLACKROCK INC. 23,868 $99,768   4.87% 0.07%
05/14/2024 QUBE RESEARCH & TECHNOLOGIES LTD 22,414 $93,691   -4.88% 0.06%
05/14/2024 NORTHERN TRUST CORP 19,292 $80,641   -0.45% 0.05%
05/15/2024 CITADEL ADVISORS LLC 17,965 $75,094   100.00% 0.05%
05/15/2024 CAPTRUST FINANCIAL ADVISORS 13,140 $54,925   -3.01% 0.04%
05/15/2024 TOWER RESEARCH CAPITAL LLC (TRC) 1,697 $7,093   -49.60% 0.00%
05/13/2024 UBS GROUP AG 767 $3,206   76,600.00% 0.00%
04/16/2024 TRIFECTA CAPITAL ADVISORS, LLC 714 $2,985   0.00% 0.00%
05/15/2024 NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 571 $2,387   0.00% 0.00%
05/15/2024 MORGAN STANLEY 426 $1,780   21,200.00% 0.00%
05/15/2024 CITADEL ADVISORS LLC 200 $836   100.00% 0.00%
05/03/2024 HOUSEHOLDER GROUP ESTATE & RETIREMENT SPECIALIST, LLC 136 $568   100.00% 0.00%
04/11/2024 SALEM INVESTMENT COUNSELORS INC 100 $418   0.00% 0.00%
05/10/2024 WELLS FARGO & COMPANY/MN 86 $357   2.38% 0.00%
05/10/2024 JPMORGAN CHASE & CO 26 $109   -75.24% 0.00%
05/15/2024 ROYAL BANK OF CANADA 0 $0   -100.00% 0.00%
05/03/2024 LARSON FINANCIAL GROUP LLC 0 $0   -100.00% 0.00%
04/23/2024 TENNESSEE VALLEY ASSET MANAGEMENT PARTNERS 0 $0   -100.00% 0.00%
05/13/2024 TEAM FINANCIAL GROUP, LLC 0 $0   -100.00% 0.00%

Armata Pharmaceuticals, Inc. institutional Ownership - Frequently Asked Questions

  • Q. Who are the largest shareholders of ARMP shares?

    A. During the previous two years, 34 institutional investors and hedge funds held shares of Armata Pharmaceuticals, Inc.. The most heavily invested institutionals were:

    BANK OF AMERICA CORP /DE/: 636,638

    VANGUARD GROUP INC: 159,209

    BRIDGEWAY CAPITAL MANAGEMENT, LLC: 110,382

    EDGEWOOD MANAGEMENT LLC: 100,000

    GEODE CAPITAL MANAGEMENT, LLC: 99,888

    SUSQUEHANNA INTERNATIONAL GROUP, LLP: 87,803

  • Q. What percentage of Armata Pharmaceuticals, Inc. stock is owned by institutional investors?

    A. 3.93% of Armata Pharmaceuticals, Inc. stock is owned by institutional investors.

  • Q. How much institutional buying is happening at ARMP ?

    A. Institutional investors have bought a total of 1.61 M shares in the last 24 months. This purchase volume represents approximately $4.29 M in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.